Loss of the putative tumor suppressor protein spinophilin is associated with poor prognosis in head and neck cancer

Human Pathology

Volumn 45, Issue 4, 2014, Pages 683-690

  Aigelsreiter, Alena Maria ^a   Aigelsreiter, Ariane ^b   Wehrschuetz, Martin ^b   Ress, Anna Lena ^b   Koller, Karin ^b   Salzwimmer, Michaela ^b   Gerger, Armin ^b   Schauer, Silvia ^b   Bauernhofer, Thomas ^b   Pichler, Martin ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Head and neck cancer; Novel tumor suppressor protein; Prognosis

Indexed keywords

PROTEIN P53; SPINOPHILIN;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CARCINOMA IN SITU; EPITHELIUM; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; SQUAMOUS EPITHELIUM; CANCER PATIENT; CANCER SURGERY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; RETROSPECTIVE STUDY; SURVIVAL RATE;

HEAD AND NECK CANCER; NOVEL TUMOR SUPPRESSOR PROTEIN; PROGNOSIS;

AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84896545826     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.11.014     Document Type: Article

References (18)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
2. A. Markovic, and C.H. Chung Current role of EGF receptor monoclonal antibodies and tyrosine kinase inhibitors in the management of head and neck squamous cell carcinoma Expert Rev Anticancer Ther 12 2012 1149 1159
3. T. Bauernhofer, M. Pichler, and E. Wieckowski et al. Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck Br J Cancer 104 2011 1641 1648
4. S. Molina-Pinelo, I. Ferrer, and C. Blanco-Aparicio et al. Down-regulation of spinophilin in lung tumours contributes to tumourigenesis J Pathol 225 2011 73 82
5. P.B. Allen, C.C. Ouimet, and P. Greengard Spinophilin, a novel protein phosphatase 1 binding protein localized to dendritic spines Proc Natl Acad Sci U S A 94 1997 9956 9961 (Pubitemid 27408172)
6. A. Satoh, H. Nakanishi, and H. Obaishi et al. Neurabin-II/spinophilin. An actin filament-binding protein with one pdz domain localized at cadherin-based cell-cell adhesion sites J Biol Chem 273 1998 3470 3475 (Pubitemid 28109767)
7. D. Sarrouilhe, A. di Tommaso, T. Metaye, and V. Ladeveze Spinophilin: from partners to functions Biochimie 88 2006 1099 1113
8. D.E. Porter, C.M. Steel, and B.B. Cohen et al. Genetic linkage analysis applied to unaffected women from families with breast cancer can discriminate high- from low-risk individuals Br J Surg 80 1993 1381 1385 (Pubitemid 23345092)
9. D.E. Porter, B.B. Cohen, and M.R. Wallace et al. Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21 Br J Surg 81 1994 1512 1515 (Pubitemid 24306008)
10. B.B. Cohen, D.E. Porter, M.R. Wallace, A. Carothers, and C.M. Steel Linkage of a major breast cancer gene to chromosome 17q12-21: results from 15 Edinburgh families Am J Hum Genet 52 1993 723 729 (Pubitemid 23310139)
11. S.A. Smith, D.F. Easton, and D. Ford et al. Genetic heterogeneity and localization of a familial breast-ovarian cancer gene on chromosome 17q12-q21 Am J Hum Genet 52 1993 767 776 (Pubitemid 23310146)
12. D.F. Easton, D.T. Bishop, D. Ford, and G.P. Crockford Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium Am J Hum Genet 52 1993 678 701 (Pubitemid 23310135)
13. A. Aigelsreiter, A.L. Ress, and K. Bettermann et al. Low expression of the putative tumour suppressor spinophilin is associated with higher proliferative activity and poor prognosis in patients with hepatocellular carcinoma Br J Cancer 108 2013 1830 1837
14. P. Estevez-Garcia, I. Lopez-Calderero, and S. Molina-Pinelo et al. Spinophilin loss correlates with poor patient prognosis in advanced stages of colon carcinoma Clin Cancer Res 19 2013 3925 3935
15. I. Ferrer, C. Blanco-Aparicio, and S. Peregrina et al. Spinophilin acts as a tumor suppressor by regulating Rb phosphorylation Cell Cycle 10 2011 2751 2762
16. S.M. Rothenberg, and L.W. Ellisen The molecular pathogenesis of head and neck squamous cell carcinoma J Clin Invest 122 2012 1951 1957
17. M.R. Ghavam-Nasiri, E. Rezaei, K. Ghafarzadegan, M. Seilanian-Toosi, and H. Malekifard Expression of p53 in colorectal carcinoma: correlation with clinicopathologic features Arch Iran Med 10 2007 38 42 (Pubitemid 46188963)
18. A. Carnero Spinophilin: a new tumor suppressor at 17q21 Curr Mol Med 12 2012 528 535